Bellicum pharmaceuticals, inc. (BLCM)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenues
Revenues

7,143

1,120

185

-

-

-

-

Grants

-

-

-

388

282

1,780

1,941

Total revenues

-

-

-

388

282

1,780

1,941

Operating expenses
Research and development

64,535

71,588

65,663

51,263

33,561

12,071

7,899

License fees

-

-

864

-

-

-

-

License fees

-

-

-

580

3,184

0

0

ARIAD restructuring costs

-

-

-

-

-

43,212

0

General and administrative

29,972

24,998

21,045

16,925

12,672

4,335

1,964

Total operating expenses

94,507

96,586

87,572

68,768

49,417

59,618

9,863

Loss from operations

-87,364

-95,466

-87,387

-68,380

-49,135

-57,838

-7,922

Other income (expense):
Other income (expense):
Interest income

1,351

1,639

1,055

909

641

35

4

Interest expense

4,280

4,199

3,672

1,760

12

1,791

51

Gain/(Loss) on disposal of assets

-

-

11

-10

-42

0

0

Gain (Loss) on Extinguishment of Debt

-

-

-1,786

0

0

-

-

Change in fair value of warrant and private placement option liabilities

19,192

0

-

-

-

24,371

0

Other expense

3,000

10

-

-

-

-

-

Total other income (expense)

-25,113

-2,570

-4,392

-861

587

-26,127

-47

Net income (loss)

-112,477

-98,036

-91,779

-69,241

-48,548

-83,965

-7,969

Preferred stock dividends

-

-

-

-

-

1,432

1,093

Net income (loss) attributable to common shareholders

-

-

-

-

-

-85,397

-9,062

Earnings Per Share, Basic and Diluted

-24.01

-24.37

-2.89

-2.57

-1.84

-34.04

-5.05

Weighted-average shares outstanding-basic and diluted (in shares)

4,684

4,023

31,714

26,950

26,346

2,508

1,795

Other comprehensive income (loss):
Unrealized gain (loss) on investment securities

-

-

-

319

-302

0

0

Net Income (Loss) Attributable to Parent

-112,477

-98,036

-91,779

-69,241

-48,548

-83,965

-7,969

Other comprehensive loss:
Unrealized gain on available-for-sale securities, net of tax

45

1

-63

-

-

-

-

Foreign currency translation adjustment

-228

-99

0

-

-

-

-

Comprehensive loss

-112,660

-98,134

-91,842

-68,922

-48,850

-83,965

-7,969

Grants
Revenues

2,143

1,120

185

-

-

-

-

License fee revenue
Revenues

5,000

0

-

-

-

-

-